|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2642999 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11793928.0 |
| Date of filing the European patent application | 2011-11-22 | |
| (97) | Date of publication of the European application | 2013-10-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-28 |
| (46) | Date of publication of the claims translation | 2017-01-25 |
| (86) | Number | PCT/US2011/061769 |
| Date | 2011-11-22 |
| (87) | Number | WO 2012/071374 |
| Date | 2012-05-31 |
| (30) | Number | Date | Country code |
| 416689 P | 2010-11-23 | US |
| (72) |
ELMORE, Steven, US
SOUERS, Andrew, US
WANG, Li Chun, US
GHAYUR, Tariq, US
PERPER, Stuart J., US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gydymo būdai, naudojant selektyviuosius BCL-2 inhibitorius |
| METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2020-11-12 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-11-22 |